Precision BioSciences
DTIL
DTIL
102 hedge funds and large institutions have $68.6M invested in Precision BioSciences in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 119 → 102 (-17)
27% less capital invested
Capital invested by funds: $93.5M → $68.6M (-$24.9M)
57% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 28
Holders
102
Holding in Top 10
1
Calls
$63K
Puts
$16K
Top Buyers
| 1 | +$3.51M | |
| 2 | +$1.65M | |
| 3 | +$872K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$863K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$552K |
Top Sellers
| 1 | -$6.8M | |
| 2 | -$3.96M | |
| 3 | -$3.28M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.61M |
| 5 |
HF
HRT Financial
New York
|
-$1.44M |